Articles

Page 77 of 78

Molecular characterization of virus-induced autoantibody responses

Authors: P Krebs, B Ludewig, Metters, Ö Türeci and U Sahin

Citation: Cancer Cell International 2004 4(Suppl 1):S59

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The Tübingen approach: identification, selection and validation of tumor-associated HLA peptides for cancer therapy

Authors: H Singh, T Weinschenk, C Lemmel, O Schoor, J Dengjel, C Gouttefangeas, S Stevanovic, P Brossart and H-G Rammensee

Citation: Cancer Cell International 2004 4(Suppl 1):S58

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells

Authors: G Waxenecker, R Kircheis, P Vondru, I Zinöcker, D Häring, D Krey, A Nechansky, GC Mudde, G Himmler and H Loibner

Citation: Cancer Cell International 2004 4(Suppl 1):S57

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Sphingosine-kinase and sphingosine-1-phosphate regulate migration of immature dendritic cells

Authors: V Jakl, S Eigenbrod, R Derwand, M Dauer, S Endres and A Eigler

Citation: Cancer Cell International 2004 4(Suppl 1):S56

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The receptor for hyaluronic acid mediated motility (RHAMM/CD168) is a leukemia associated antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML)

Authors: J Greiner, M Ringhoffer, L Li, T Barth, T Wölfel, H Döhner and M Schmitt

Citation: Cancer Cell International 2004 4(Suppl 1):S55

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene

Authors: P Öhlschläger, M Pes, W Osen, M Dürst, A Schneider, L Gissmann and AM Kaufmann

Citation: Cancer Cell International 2004 4(Suppl 1):S53

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
New TRP-2-derived T helper epitopes identified in HLA-DRB1*0301 transgenic mice elicit spontaneous T cell responses in HLA-DRB1*03 and HLA-DRB1*04 melanoma patients

Authors: M Song, W Osen, D Thomas, N Daniel, XD Nguyen, J Mueller-Berghaus, H Kropshofer, D Schadendorf and A Paschen

Citation: Cancer Cell International 2004 4(Suppl 1):S51

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines

Authors: MS von Bergwelt-Baildon, B Maecker, F Fiore, LM Nadler and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S49

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients in vivo: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)

Authors: AM Asemissen, C Scheibenbogen, A Letsch, K Hellstrand, K Gehlsen, E Thiel and U Keilholz

Citation: Cancer Cell International 2004 4(Suppl 1):S47

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Survival and homing of ex vivo expanded donor derived dendritic cells after allogeneic BMT

Authors: C Schimmelpfennig, S Schulz, C Arber, J Baker, I Tarner, J McBride, CG Fathman, C Contag and R Negrin

Citation: Cancer Cell International 2004 4(Suppl 1):S45

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Phase I/II study of vaccination with immature and mature dendritic cells in patients with melanoma and renal cell carcinoma

Authors: M Petrini, L Fiammenghi, L Ridolfi, M Stefanelli, G Migliori, C Brolli, A Riccobon and R Ridolfi

Citation: Cancer Cell International 2004 4(Suppl 1):S44

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Optimizing the antigen loading of dendritic cells with exogenous peptides

Authors: ES Schultz, D Dieckmann, B Ring and G Schuler

Citation: Cancer Cell International 2004 4(Suppl 1):S43

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Parvovirus H1-induced tumor cell death enhances human immune response via crosspresentation of dendritic cells

Authors: M Zeidler, J Cornelis, T Woelfel, J Rommeleare, PR Galle, M Heike and M Moehler

Citation: Cancer Cell International 2004 4(Suppl 1):S42

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Efficient in vitro expression of human reverse transcriptase (hTERT) in dendritic cells of lung cancer patients using RNA electrotransfection

Authors: A-K Brill, W Klapper, U Weingartz, I Bolz, A Heiser, D Kabelitz, M Kneba and B Gahn

Citation: Cancer Cell International 2004 4(Suppl 1):S41

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The European Searchable Tumour Cell and Databank, ESTDAB, as a tool for research in cancer immunology

Authors: L Müller, D Schadendorf, S Stevanovic, A Knights, E Badalian, L Wedel and G Pawelec

Citation: Cancer Cell International 2004 4(Suppl 1):S40

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial

Authors: B Hildenbrand, A Langenkamp, B Sauer, C Stoll, O Constantiniu, R Leo, C Unger and M Azemar

Citation: Cancer Cell International 2004 4(Suppl 1):S39

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

Authors: B Gückel, S Stumm, C Rentzsch, S Kayser, I Gruber, A Marmé, J Huober, F Autschbach, S Meuer and D Wallwiener

Citation: Cancer Cell International 2004 4(Suppl 1):S38

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Particulate antigenic structures: highly immunogenic carriers for T cell epitopes derived from tumour antigens

Authors: M Brinkman, J Walter, S Grein, MJW Thies, C Reiser and J Hess

Citation: Cancer Cell International 2004 4(Suppl 1):S37

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Chimeric carrier proteins for targeted delivery of tumor antigens to professional antigen presenting cells

Authors: F Rohrbach, R Weth, M Kursar, H-W Mittrücker and W Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S36

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Identification of a melanoma-associated chondroitin sulfate proteoglycan (MCSP) peptide recognized by CD4⁺ T lymphocytes on human melanoma cells

Authors: CS Erfurt, C Heirman, K Thielemans, G Schuler and ES Schultz

Citation: Cancer Cell International 2004 4(Suppl 1):S35

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Induction of leukemia reactive, allogeneic donor lymphocytes

Authors: AK Kaskel, T Portugal, H Veelken and J Finke

Citation: Cancer Cell International 2004 4(Suppl 1):S34

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Tumor-specific murine T cell receptors displace endogenous TCRs in human T cells

Authors: R-H Voss, S Thomas, J Kuball, R Engel, M Brkic, P Guillaume, P Romero, C Huber and M Theobald

Citation: Cancer Cell International 2004 4(Suppl 1):S33

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The kinetics of accumulation of adoptively transferred ovalbumin-specific T cells in a transgenic, ovalbumin-expressing murine tumor

Authors: R Agger, MS Petersen, CC Fleischer and ME Hokland

Citation: Cancer Cell International 2004 4(Suppl 1):S32

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Isolated γδ T cells express natural cytotoxicity receptors

Authors: M von Lilienfeld-Toal, J Nattermann, G Feldmann and IGH Schmidt-Wolf

Citation: Cancer Cell International 2004 4(Suppl 1):S31

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Enrichment of functional CD8 memory T cells specific for MUC1 in Bone Marrow of Multiple Myeloma Patients

Authors: M Witzens, C Choi, M Bucur, M Feuerer, N Sommerfeldt, A Trojan, A Ho, V Schirrmacher, H Goldschmidt and P Beckhove

Citation: Cancer Cell International 2004 4(Suppl 1):S30

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
NFκB activation and TGFβ loss signatures are prominent ex vivo responses of peripheral blood mononuclear cells

Authors: T Zander, D Re, S Beyer, M Hellmich, A Popov, I Büchmann, J Wolf, S Debey and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S29

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Modulation of tumour directed B cell responses by NK cells

Authors: M Jensen, A Buhl, C Hoyer, S Schmitz, S Tawadros, H Harald-Sedlacek, J Schultze and F Berthold

Citation: Cancer Cell International 2004 4(Suppl 1):S28

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Assessment of genes associated with immune activation and regulation in pancreatic cancer patients

Authors: M Gasser, TF Mueller, A Müller, M Becker, N Schramm, M Büter, AM Gassel, A Thiede, H-J Gassel and AM Waaga-Gasser

Citation: Cancer Cell International 2004 4(Suppl 1):S27

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Regulation of p53 tumor specific immune responses in colorectal cancer patients

Authors: M Büter, M Gasser, T Mueller, D Meyer, N Schramm, A Müller, A Trumpfheller, S Müller, A Thiede and AM Waaga-Gasser

Citation: Cancer Cell International 2004 4(Suppl 1):S26

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Bisphosphonic acid acts as Gamma/Delta T cell activating antigen and has direct cytotoxic activity against pancreatic carcinoma cells

Authors: J Schmidt, Mv Lilienfeld-Toal, MW Büchler and A Märten

Citation: Cancer Cell International 2004 4(Suppl 1):S25

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Release of iC3b from apoptotic pancreatic tumor cells induces tolerance by binding to immature dendritic cells

Authors: J Schmidt, MW Büchler and A Märten

Citation: Cancer Cell International 2004 4(Suppl 1):S24

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Inhibition of signaling via erbB-receptors by antibodies that target the Lewis Y-antigen

Authors: G Waxenecker, M Klinger, H Farhan, M Freissmuth, G Himmler, E Janzek, GC Mudde and H Loibner

Citation: Cancer Cell International 2004 4(Suppl 1):S23

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Increased effector functions of a monoclonal antibody by glycoform engineering

Authors: G Waxenecker, M Schuster, P Umana, P Brünker, I Froihofer, S Wiederkum, C Schwager, H Klug, GC Mudde, G Himmler and H Loibner

Citation: Cancer Cell International 2004 4(Suppl 1):S22

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Limiting the risk of immunogenicity by identification and removal of T-cell epitopes (DeImmunisation™)

Authors: K Hellendoorn, T Jones, J Watkins, M Baker, A Hamilton and F Carr

Citation: Cancer Cell International 2004 4(Suppl 1):S20

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

Authors: M Zöller

Citation: Cancer Cell International 2004 4(Suppl 1):S19

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

Authors: A Bender, J Karbach, A Neumann, M Biskamp, D Jäger, S Gnjatic, E Hoffman, LJ Old, A Knuth and E Jäger

Citation: Cancer Cell International 2004 4(Suppl 1):S18

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Transitory response to vaccination with PSCA-/PSA-peptide loaded, autologous dendritic cells in patients with metastatic, hormone-refractory prostate cancer

Authors: AK Kaskel, R Zeiser, R Jochim, W Schultze-Seemann, CF Waller and H Veelken

Citation: Cancer Cell International 2004 4(Suppl 1):S16

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The role of glycosylation as a modulator for signalling strength in T cells

Authors: B Hauptrock, J Kuball, R-H Voss, M Brkic, C Huber and M Theobald

Citation: Cancer Cell International 2004 4(Suppl 1):S14

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Reversible HLA multimers (streptamers) for isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens

Authors: J Neudorfer, B Schmidt, K Huster, M Schiemann, T Schmidt, H Wagner, C Peschel, DH Busch and H Bernhard

Citation: Cancer Cell International 2004 4(Suppl 1):S12

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Adoptive T cell therapy using antigen-specific CD8⁺ T cells for the treatment of patients with metastatic melanoma: a phase I clinical study

Authors: N Meidenbauer, S Vogl, M Laumer, J Heymann, R Andreesen and A Mackensen

Citation: Cancer Cell International 2004 4(Suppl 1):S10

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Rapid functional exhaustion and deletion of cytotoxic T lymphocytes following immunization with recombinant adenovirus

Authors: E Scandella, P Krebs, B Odermatt and B Ludewig

Citation: Cancer Cell International 2004 4(Suppl 1):S8

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM

Authors: C Uherek, T Müller, T Tonn, B Uherek, H-G Klingemann and WS Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S7

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
MMP-7 inhibits CTL – tumor cell interaction

Authors: S Gregor, V Alla, J Kuball, M Theobald, PR Galle, D Strand and S Strand

Citation: Cancer Cell International 2004 4(Suppl 1):S6

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Increased frequency of CTLA4⁺ TGFβ⁺ CD4⁺ CD25⁺ T cells in peripheral blood of patients with chronic lymphatic leukemia and multiple myeloma

Authors: M Beyer, M Kochanek, M von Bergwelt-Baildon, A Popov, J Wolf and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S5

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy

Authors: Y Wachter, J Brünke, S Schuster, K Barbin, M Peipp, T Valerius, M Gramatzki, G Fey and R Repp

Citation: Cancer Cell International 2004 4(Suppl 1):S4

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Tolerability and efficacy of the trifunctional antibody removab^® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

Authors: P Wimberger, A Burges, V Gorbounova, H Sommer, B Schmalfeldt, J Pfisterer, M Lichinitser, A Makhson, M Ströhlein, W Eiermann, M Biakhov, V Moiseenko, A du Bois and R Kimmig

Citation: Cancer Cell International 2004 4(Suppl 1):S3

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Antibody-based immunoreceptors: the impact of signalling domain, binding affinity and costimulation

Authors: A Hombach, C Heuser and H Abken

Citation: Cancer Cell International 2004 4(Suppl 1):S2

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

Authors: R Weth, M Biburger and W Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S1

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients

Malignant peripheral nerve sheath tumors (MPNSTs) are neoplasms leading to death in most cases. Patients with Neurofibromatosis type 1 have an increased risk of developing this malignancy. The metabolites of t...

Authors: Silke Frahm, Andreas Kurtz, Lan Kluwe, Faris Farassati, Reinhard E Friedrich and Victor F Mautner

Citation: Cancer Cell International 2004 4:4

Content type: Primary research Published on: 17 May 2004
- View Full Text
- View PDF
Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring

Flow cytometry, DNA fragmentation, ion ratiomateric analysis and NMR peaks characterized drug chemosensitivity of antineoplastic drugs. Hypotheses were: 1. The chemosensitive effect of different cancer cell li...

Authors: Rakesh Sharma and Richard Kline

Citation: Cancer Cell International 2004 4:3

Content type: Primary research Published on: 19 March 2004
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

On the blog

Institutional membership

Funding your APC

​​​​​​​​​

Cancer Cell International

Contact us